Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2019

Apr 3, 2019

33193_dirs_2019-04-03_1a0e4362-82aa-4c7b-ae5d-3eccff05f881.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-04-01

Reporting Person: Weinand Dieter (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-01 Stock Option (right to buy) $15.50 A 13500 Acquired 2029-04-01 Common Stock (13500) Direct

Footnotes

F1: The shares underlying this option vest entirely on April 1, 2020.